International Clinical Trial: Sacubitril/Allisartan Versus Amlodipine for Hypertensive Patients With Overweight or Obesity: A Multicenter, Open-Label, Randomized Controlled Trial

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115088) titled 'Sacubitril/Allisartan Versus Amlodipine for Hypertensive Patients With Overweight or Obesity: A Multicenter, Open-Label, Randomized Controlled Trial' on Dec. 22, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Peking University People's Hospital

Condition: Mild to moderate essential hypertension AND overweight or obese

Intervention: Amlodipine tablet group:Take 5mg of amlodipine orally

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-12-22

Target Sample Size: Amlodipine tablet group:52;Sacubitril arisartan group:52;

Countries of Recruitmen...